미오글로빈 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 최종 용도별, 지역별, 부문별 예측(2024-2032년)

The global myoglobin market size is expected to reach USD 144.84 million by 2032, according to a new study by Polaris Market Research. The report "Myoglobin Market Share, Size, Trends, Industry Analysis Report, By Product Type (Human Myoglobin And Animal Myoglobin); By End Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Myoglobin testing is essential in surgical settings, especially during procedures such as open-heart surgeries, where monitoring cardiac health is paramount. As the number of surgical interventions, including cardiac surgeries, continues to rise, so does the demand for myoglobin testing products and services.

The exploration of myoglobin's applications in various fields, including biotechnology, pharmaceuticals, and food safety, drives demand for research tools, reagents, and analytical instruments. Ongoing research efforts aimed at understanding myoglobin's role in physiology, pathology, and therapeutic interventions contribute to market demand.

Growing emphasis on health and wellness among consumers worldwide and increased demand for protein-rich food products from consumers to maintain a healthy diet are major factors driving the demand for myoglobin. As the global population continues to grow, the demand and consumption of meat and processed food products are growing rapidly, which drives the demand for myoglobin as it is mainly found in meat products and is a good source of protein.

Furthermore, ongoing research & development activities that are mainly focused on improving the production and utilization of myoglobin and exploring new potential applications across various industries further contribute to market growth. The continuous expansion of the food industry and the development of new meat products and meat alternatives containing myoglobin are further likely to propel product demand across the globe.

Moreover, myoglobin is also being used in medical diagnostics, especially in tests for heart attacks and muscle-related disorders. The substantial increase in the incidences of muscle and heart-related disorders is forcing healthcare organizations to deploy myoglobin tests across various health settings.

In addition to the rising concerns related to environmental sustainability and animal welfare worldwide, the demand for meat alternatives and myoglobin-rich plant-based proteins over traditional meat products is growing at a rapid pace. Also, there have been numerous advancements in food processing technologies that enable the production of myoglobin-rich products with better texture and aroma while meeting consumer preferences for healthy and natural protein sources.

Myoglobin Market Report Highlights

In 2023, the human myoglobin segment accounted for the largest market share, attributed to growing awareness about the importance of myoglobin in several diagnostic tests.

The hospital segment is expected to witness the fastest-growing CAGR during the forecast period on account of rising healthcare expenditure and growing proliferation for timely and accurate diagnosis of diseases in hospitals.

In 2023, the North American region dominated the largest market share, owing to the robust presence of well-established healthcare infrastructure and the prevalence of heart diseases.

The key market players include Abbott Laboratories, Abcam Plc, Biomerieux, Bio-Rad Laboratories, Bio-Techne Corporation, Randox Laboratories Ltd, and more.

Polaris Market Research has segmented the myoglobin market report based on product type, end use, and region:

Myoglobin, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

• Human Myoglobin
• Animal Myoglobin

Myoglobin, End User Outlook (Revenue - USD Million, 2019 - 2032)

• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Others

Myoglobin, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of APAC
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of LA
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Myoglobin Market Insights

• 4.1. Myoglobin Market - Industry Snapshot
• 4.2. Myoglobin Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing prevalence of cardiovascular diseases and rising aging population
    • 4.2.1.2. Growing research & development activities
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Lack of skilled professionals and stringent regulations
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Myoglobin Industry trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Myoglobin Market, by Product Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Myoglobin, by Product Type, 2019-2032 (USD Million)
• 5.3. Human Myoglobin
  • 5.3.1. Global Myoglobin Market, by Human Myoglobin, by Region, 2019-2032 (USD Million)
• 5.4. Animal Myoglobin
  • 5.4.1. Global Myoglobin Market, by Animal Myoglobin, by Region, 2019-2032 (USD Million)

6. Global Myoglobin Market, by End Use

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Myoglobin Market, by End Use, 2019-2032 (USD Million)
• 6.3. Hospitals
  • 6.3.1. Global Myoglobin Market, by Hospitals, by Region, 2019-2032 (USD Million)
• 6.4. Diagnostic Laboratories
  • 6.4.1. Global Myoglobin Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)
• 6.5. Research & Academic Institutes
  • 6.5.1. Global Myoglobin Market, by Research & Academic Institutes, by Region, 2019-2032 (USD Million)
• 6.6. Others
  • 6.6.1. Global Myoglobin Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Myoglobin Market, by Geography

• 7.1. Key findings
• 7.2. Introduction
  • 7.2.1. Myoglobin Market Assessment, By Geography, 2019-2032 (USD Million)
• 7.3. Myoglobin Market - North America
  • 7.3.1. North America: Myoglobin Market, by End Use, 2019-2032 (USD Million)
  • 7.3.2. North America: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.3.3. Myoglobin Market - U.S.
    • 7.3.3.1. U.S.: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.3.3.2. U.S.: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.3.4. Myoglobin Market - Canada
    • 7.3.4.1. Canada: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.3.4.2. Canada: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
• 7.4. Myoglobin Market - Europe
  • 7.4.1. Europe: Myoglobin Market, by End Use, 2019-2032 (USD Million)
  • 7.4.2. Europe: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.3. Myoglobin Market - UK
    • 7.4.3.1. UK: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.3.2. UK: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.4. Myoglobin Market - France
    • 7.4.4.1. France: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.4.2. France: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.5. Myoglobin Market - Germany
    • 7.4.5.1. Germany: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.5.2. Germany: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.6. Myoglobin Market - Italy
    • 7.4.6.1. Italy: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.6.2. Italy: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.7. Myoglobin Market - Spain
    • 7.4.7.1. Spain: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.7.2. Spain: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.8. Myoglobin Market - Netherlands
    • 7.4.8.1. Netherlands: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.8.2. Netherlands: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.4.9. Myoglobin Market - Russia
    • 7.4.9.1. Russia: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.4.9.2. Russia: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
• 7.5. Myoglobin Market - Asia Pacific
  • 7.5.1. Asia Pacific: Myoglobin Market, by End Use, 2019-2032 (USD Million)
  • 7.5.2. Asia Pacific: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.3. Myoglobin Market - China
    • 7.5.3.1. China: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.3.2. China: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.4. Myoglobin Market - India
    • 7.5.4.1. India: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.4.2. India: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.5. Myoglobin Market - Malaysia
    • 7.5.5.1. Malaysia: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.5.2. Malaysia: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.6. Myoglobin Market - Japan
    • 7.5.6.1. Japan: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.6.2. Japan: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.7. Myoglobin Market - Indonesia
    • 7.5.7.1. Indonesia: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.7.2. Indonesia: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.5.8. Myoglobin Market - South Korea
    • 7.5.8.1. South Korea: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.5.8.2. South Korea: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
• 7.6. Myoglobin Market - Middle East & Africa
  • 7.6.1. Middle East & Africa: Myoglobin Market, by End Use, 2019-2032 (USD Million)
  • 7.6.2. Middle East & Africa: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.6.3. Myoglobin Market - Saudi Arabia
    • 7.6.3.1. Saudi Arabia: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.6.3.2. Saudi Arabia: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.6.4. Myoglobin Market - UAE
    • 7.6.4.1. UAE: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.6.4.2. UAE: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.6.5. Myoglobin Market - Israel
    • 7.6.5.1. Israel: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.6.5.2. Israel: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.6.6. Myoglobin Market - South Africa
    • 7.6.6.1. South Africa: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.6.6.2. South Africa: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
• 7.7. Myoglobin Market - Latin America
  • 7.7.1. Latin America: Myoglobin Market, by End Use, 2019-2032 (USD Million)
  • 7.7.2. Latin America: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.7.3. Myoglobin Market - Mexico
    • 7.7.3.1. Mexico: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.7.3.2. Mexico: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.7.4. Myoglobin Market - Brazil
    • 7.7.4.1. Brazil: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.7.4.2. Brazil: Myoglobin Market, by Product Type, 2019-2032 (USD Million)
  • 7.7.5. Myoglobin Market - Argentina
    • 7.7.5.1. Argentina: Myoglobin Market, by End Use, 2019-2032 (USD Million)
    • 7.7.5.2. Argentina: Myoglobin Market, by Product Type, 2019-2032 (USD Million)

8. Competitive Landscape

• 8.1. Expansion and Acquisition Analysis
  • 8.1.1. Expansion
  • 8.1.2. Acquisitions
• 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

• 9.1. Abbott Laboratories
  • 9.1.1. Company Overview
  • 9.1.2. Financial Performance
  • 9.1.3. Product Benchmarking
  • 9.1.4. Recent Development
• 9.2. Abcam Plc
  • 9.2.1. Company Overview
  • 9.2.2. Financial Performance
  • 9.2.3. Product Benchmarking
  • 9.2.4. Recent Development
• 9.3.Biomerieux
  • 9.3.1. Company Overview
  • 9.3.2. Financial Performance
  • 9.3.3. Product Benchmarking
  • 9.3.4. Recent Development
• 9.4. Bio-Rad Laboratories.
  • 9.4.1. Company Overview
  • 9.4.2. Financial Performance
  • 9.4.3. Product Benchmarking
  • 9.4.4. Recent Development
• 9.5. Bio-Techne Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Development
• 9.6. Randox Laboratories Ltd
  • 9.6.1. Company Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Development
• 9.7. Roche Diagnostics
  • 9.7.1. Company Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Development
• 9.8. Siemens Healthcare
  • 9.8.1. Company Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Development
• 9.9. Thermo Fisher Scientific Inc
  • 9.9.1. Company Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Development
• 9.10. Tosoh Corporation
  • 9.10.1. Company Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Development